Kobatake T, Watanabe Y, Matsuzawa Y, Tokunaga K, Fujioka S, Kawamoto T, Keno Y, Tarui S, Yoshida H
Second Department of Internal Medicine, Osaka University Medical School, Japan.
J Lipid Res. 1991 Feb;32(2):191-6.
Age-related changes in alpha 1-, alpha 2-, and beta-catecholamine receptors on membrane of rat epididymal fat cells were investigated. Both young (6 weeks old, weight about 190 g) and aged (20 weeks old, weight about 490 g) Sprague-Dawley male rats were used. For the alpha 1-adrenoceptor binding experiment, we developed a novel analytical method using the hydrophilic alpha 1-receptor selective antagonist, [3H]bunazosin. The binding of [3H]bunazosin to its binding sites was rapid, reversible, saturable, and stereospecific. Scatchard binding analysis showed a single class of binding site. The sites were characterized as alpha 1-adrenoceptors by inhibition experiments using various agonists and antagonists. The number of maximum binding sites (Bmax) of alpha 1-receptor binding was 37.0 +/- 6.5 (young) versus 24.0 +/- 3.2 (aged) fmol/mg protein (P less than 0.01). [3H]Rauwolscine and [3H]CGP-12177 were used for alpha 2- and beta-receptor binding, respectively. In alpha 2-receptor detection using [3H]rauwolscine as a ligand, Bmax increased markedly from 19.8 +/- 4.9 to 86.2 +/- 19.5 fmol/mg protein (P less than 0.01). In contrast, Bmax for beta-receptor decreased from 69.7 +/- 9.7 to 45.4 +/- 13.9 fmol/mg protein with increasing rat age (P less than 0.05). Kd showed no change in each of the binding experiments between young and aged rats. The cell volume increased from 0.07 +/- 0.02 to 0.15 +/- 0.06 nl. It is implied that anti-lipolytic activity strengthened on the whole mainly with the marked increase of alpha 2-receptor number and decrease of beta-receptor number.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了大鼠附睾脂肪细胞膜上α1、α2和β肾上腺素能受体的年龄相关变化。使用了年轻(6周龄,体重约190克)和老年(20周龄,体重约490克)的Sprague-Dawley雄性大鼠。对于α1肾上腺素能受体结合实验,我们开发了一种使用亲水性α1受体选择性拮抗剂[3H]布那唑嗪的新型分析方法。[3H]布那唑嗪与其结合位点的结合是快速、可逆、饱和且立体特异性的。Scatchard结合分析显示为单一类别的结合位点。通过使用各种激动剂和拮抗剂的抑制实验,将这些位点表征为α1肾上腺素能受体。α1受体结合的最大结合位点数(Bmax)为37.0±6.5(年轻)对24.0±3.2(老年)fmol/mg蛋白质(P<0.01)。[3H]育亨宾和[3H]CGP-12177分别用于α2和β受体结合。在使用[3H]育亨宾作为配体的α2受体检测中,Bmax从19.8±4.9显著增加至86.2±19.5 fmol/mg蛋白质(P<0.01)。相反,随着大鼠年龄增长,β受体的Bmax从69.7±9.7降至45.4±13.9 fmol/mg蛋白质(P<0.05)。在年轻和老年大鼠的每个结合实验中,解离常数(Kd)均无变化。细胞体积从0.07±0.02增加至0.15±0.06 nl。这意味着抗脂解活性总体上增强,主要是由于α2受体数量显著增加和β受体数量减少。(摘要截短于250字)